Thanks to the innovative methods, we can help patients with a low chance of conceiving

“At Reprofit, we believe that every story deserves an individual approach — no matter how difficult the situation may be. Our work combines top-tier medical care, a compassionate attitude, and in-house scientific research that directly enhances patient treatment.”

One of the most recent examples of this approach is a study led by our research team under Zuzana Holubcová, published in the April 2024 issue of the Journal of Assisted Reproduction and Genetics.

What does the new study reveal?

The study focuses on evaluating egg quality and embryo development in patients with minimal chances of achieving pregnancy. Through the use of advanced laboratory techniques and in-depth cellular analysis, the team was able to better understand the causes of recurrent failure and propose new treatment strategies.

Key takeaways from the study:

• Improved identification of developmental errors in embryos
• Use of advanced microscopy to assess cellular quality
• Direct impact on refining treatment approaches for even the most challenging cases

🧬 Read the full study in English 

Springer Journal Article